Rentokil Initial plc: 2024 Interim Results Summary
Business Context and Reporting Period
This Form 6-K reports the unaudited interim results for Rentokil Initial plc for the six months ended 30 June 2024, announced on 25 July 2024. The Group operates globally in Pest Control, Hygiene & Wellbeing, and France Workwear. The reporting period highlights the ongoing integration of the Terminix acquisition and the execution of the "Right Way 2" growth plan in North America.
Key Financial Metrics (H1 2024)
| Metric | H1 2024 (AER) | H1 2023 (AER) | Change | H1 2024 (CER) | H1 2023 (CER) | Change |
|---|---|---|---|---|---|---|
| Revenue | £2,706m | £2,671m | +1.3% | £2,756m | £2,650m | +4.0% |
| Organic Revenue Growth | 2.8% | |||||
| Adjusted Operating Profit | £445m | £437m | +1.9% | £455m | £434m | +4.7% |
| Adjusted Operating Margin | 16.5% | 16.4% | +10bps | 16.5% | 16.4% | +10bps |
| Adjusted Profit Before Tax | £383m | £377m | +1.8% | £394m | £371m | +6.1% |
| Statutory Profit Before Tax | £253m | £240m | +5.6% | N/A | ||
| Adjusted EBITDA | £611m | £602m | +1.5% | N/A | ||
| Free Cash Flow | £172m | £229m | -24.9% | N/A | ||
| Diluted Adjusted EPS | 11.60p | 11.41p | +1.7% | N/A | ||
| Net Debt | £3,222m | £3,146m | Inc. £76m | N/A | ||
| Net Debt / EBITDA | 2.8x | 2.8x | Flat | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Statutory revenue grew 1.3% (AER), driven by a 4.0% increase at constant exchange rates (CER). Organic revenue growth was 2.8%.
- North America Performance: Organic revenue growth in North America Pest Control improved quarter-on-quarter (1.0% in Q1 to 1.5% in Q2). Total North America organic revenue was up 1.3%, though dragged down by the closure of the Paragon distribution business (effective April 1, 2024).
- Regional Highlights: Europe (inc. LATAM) revenue grew 7.0% (CER), UK & Sub-Saharan Africa grew 13.2% (CER), and Pacific grew 10.4% (CER). Hygiene & Wellbeing revenue grew 9.3% (CER) globally.
- Profitability: Adjusted Operating Profit increased 4.7% (CER). Margins expanded slightly across most regions, with North America Adjusted Operating Margin reaching 18.6%.
- Cash Flow: Free Cash Flow decreased by £57m to £172m, primarily due to a £97m working capital outflow (softer debtor performance and supplier payment timing) and higher capital expenditure (£105m vs £102m).
- Dividends: Interim dividend per share increased 14.9% to 3.16p.
Guidance, Outlook, and Management Commentary
- North America Strategy: Management is committed to re-accelerating organic growth in North America. An additional $25m investment (c.$15m P&L spend in FY24) has been committed to growth initiatives, including digital marketing, sales capability, and customer retention.
- Full Year Outlook:
- North America Organic Revenue: Expected to grow within the guided 2-4% range, albeit at the lower end.
- Adjusted Operating Profit: A net revision of c.$15m (c.£12m) downward is expected for the full year, reflecting additional growth investments in H2.
- Margins: Group Adjusted Operating Margin is expected to be marginally ahead of FY23.
- Cash Flow: Adjusted Free Cash Flow conversion guidance remains 80-90%.
- Deleveraging: Further modest deleveraging is anticipated.
- Terminix Integration: Integration is on plan. Phase 3 (branch integrations) launched in June. Cumulative gross synergies delivered to date are $162m ($58m in H1). Costs to achieve synergies for FY24 are revised down to $80m-$90m.
- Acquisitions: 23 acquisitions completed in H1 with annualised revenues of c.£81m. Full year M&A spend guidance revised to £200m-£250m.
- Currency Change: The Group plans to change its presentation currency from GBP to USD starting 1 January 2025.
Investor Verification Checklist
- North America Growth Trajectory: Verify if the Q2 improvement in organic growth (1.5%) sustains through H2 to meet the lower end of the 2-4% full-year guidance.
- Working Capital Normalization: Confirm the expected unwind of the £97m H1 working capital outflow in H2 to support the 80-90% cash conversion target.
- Terminix Synergy Realization: Monitor the delivery of the remaining $54m gross synergies forecast for H2 and the execution of branch integrations.
- Termite Warranty Provisions: Review the sensitivity of the £233m provision to changes in claim rates and values, noting the 11% increase in in-year costs per claim in H1.
- FX Impact: Assess the impact of the planned shift to USD reporting and the current FX headwinds (estimated -£30m to -£40m impact on Adjusted Operating Profit).